Every day, thousands of executives rely on Fierce Pharma and Fierce Biotech for the latest news, analysis and coverage on drugs and the companies that make them. The Fierce Editorial Team is excited to be delving into some of the upcoming year's hottest topics with an all-star lineup of speakers at Fierce JPM Week on January 9-10th at the Hyatt Regency San Francisco. Be sure to join them and over 500 senior biotech and pharma executives at this one-of-a-kind event focused on learning, networking and connecting. Below is a quick snapshot of the sessions led by our award-winning editorial team VIEW THE AGENDA>> Register now and save $200 with the Advanced Rate! Prices increase December 22nd. |
|
|
DAY ONE
Tuesday, January 9, 2024 |
|
|
Exclusive Executive Interviews |
|
|
Johanna Mercier Chief Commercial Officer Gilead |
| Shreeram Aradhye President, Development and Chief Medical Officer Novartis |
| Jürgen Eckhardt, MD, MBA
EVP, Head of Leaps by Bayer and Head of Pharmaceuticals Business Development, Licensing & Open Innovation
Bayer Pharmaceuticals |
|
|
- Exploring the Inflation Reduction Act: Pharma's Legal Battles and the Future of Innovation
- Angus Liu, Senior Writer, Fierce Pharma
- Meenakshi Datta, Partner, Sidley Austin LLP
- Phil Sclafani, Principal, PwC US
- Greg Verdine, PhD, Venture Partner, Andreessen Horowitz; and CEO LifeMine Therapeutics
- Troy Wilson, Ph.D., J.D., President and CEO, Kura Oncology
- A Look at Biopharma M&A and Shifting Deal Dynamics
- Max Bayer, Staff Writer, Fierce Biotech
- Elizabeth Naldi Jacob, Head of Oncology BD & Headquarters Transactions, Merck
- Athena Countouriotis, MD, CEO and Co-Founder, Avenzo Therapeutics
- Issei Tsukamoto, Ph.D., SVP, Head of Business Development, Astellas Pharma Inc.
- Advancements and Challenges in Cell & Gene Therapy Manufacturing
- Fraiser Kansteiner,Staff Writer, Fierce Pharma
- Jenny Holt, PMP, Chief Development Officer, Ray Therapeutics
- Chris McDonald, Global Head of Technical Operations, Kite, A Gilead Company
- Morten Sogaard, Ph.D, President and Division Head of Research and Technical Operations, Astellas Gene Therapies
- Brian Riley, Chief Manufacturing Officer, Beam Therapeutics
|
|
|
DAY TWO
Wednesday, January 10, 2024 |
|
|
Exclusive Executive Interviews |
|
|
| Shehnaaz Suliman, M.D., MBA, M.Phil.
Chief Executive Officer ReCode Therapeutics |
| Marianne De Backer, M.Sc., Ph.D., MBA Chief Executive Officer Vir Biotechnology |
| |
|
- Crossovers, Megarounds and IPOs: Biotechs Always Find a Way
- Gabrielle Masson, Staff Writer, Fierce Biotech
- Kristine Ball, CEO, Antiva Biosciences Inc.
- Jun Yoon, CFO, Structure
- Ken Song, CEO, RayzeBio
- Julie Grant, General Partner, Canaan
- Jackie Spencer, Head of Relationship Management for Life Science and Healthcare Banking, Silicon Valley Bank
- Oncology's Next Frontier: ADCs, Radiopharma and the Future of Cancer Treatment
- Max Bayer, Staff Writer, Fierce Biotech
- Daejin Abidoye, VP, Therapeutic Area Head Solid Tumor, AbbVie
- David Weinstock, M.D., VP, Discovery Oncology, Merck Research Laboratories
- Lori Lyons-Williams, President & CEO, Abdera Therapeutics
|
|
|
Special Offer on Group Rates! |
|
|
| Send Your Team and Save
Send your team (3 or more) and each member of your team can register for just $595/person with code JPMGROUP.* DEADLINE: December 15, 2023 |
|
|
*PLEASE NOTE: This offer is only available to qualified Pharma, Biotech and Medical Device companies and requires a team of 3 or more. Your team must be registered by December 8th or you will be required to pay the current price at the time that you registered. |
|
|
Learn About Partnership Opportunities |
|
|
| | | 2 Days Great Content and Opportunities to Network |
|
|
| Position your company as a thought leader, promote your brand and engage with leading Biotech and Pharma Executives. Contact us today to learn why Fierce JPM Week is the right show for you! |
|
|
Thank You to Our Partners |
|
|
If you no longer wish to receive promotion on this event, simply unsubscribe.
Refer to our Privacy Policy.
Fierce Life Sciences is a division of Questex LLC.
685 3rd Ave 21st Floor New York, NY 10017 Contact Us
© 2022 Questex LLC. All Rights Reserved.
Reproduction in whole or in part is prohibited without written permission. |
|
|
|
